Stent delivery systems and methods for making and using stent delivery systems are disclosed. An example stent delivery system may include a guide member having a proximal portion and a distal portion. A stent may be disposed about the distal portion of the guide member. The stent may have a wall having an opening formed therein. A pusher member may be disposed about the guide member and positioned proximal of the stent. A holding filament may be disposed at the opening and may extend to the proximal portion of the guide member. The holding filament may be configured to releasably secure the position of the stent relative to the pusher member. The holding filament may be releasable from the stent independently of movement of the guide member.

A stent is to be placed within a biological lumen (HP) and is provided with: stent parts that have a tubular shape and can expand and shrink in a radial direction that is approximately perpendicular to the axial direction; and transformation means that can transform the stent parts from a reduced diameter state to an expanded diameter state. The transformation means have: first linear members wound around the outer circumferential surfaces of the stent parts; and holding members for holding the first linear members non-detachably from the stent parts. The first linear members are engaged with the holding members to maintain the stent parts in the reduced diameter state, and the engagement is released to transform the stent parts from the reduced diameter state to the expanded diameter state.

A stent is disclosed that has an elongated body composed of a bioabsorbable polymer having a proximal end, a distal end, two open spiral channels formed on the exterior surface of the body to provide fluid communication between the proximal end and the distal end. The stent also has a central lumen open at the proximal and distal ends of the stent for the passage of a guide wire. A method for using the stent and a kit containing the stent are also disclosed.

According to an aspect, a method of cholecystitis treatment includes: forming a communication hole that communicates a gallbladder and a duodenum; and arranging a bypass tube extending from a cystic duct to the duodenum through an inside of the gallbladder and the communication hole.

The present disclosure relates generally to stents, systems, and methods for anchoring devices within a body lumen by cooperation between the device and the body musculature. A device comprising an elongate tubular member may be deployed within a body lumen, where the body lumen includes a sphincter that regulates flow through the body lumen. The elongate tubular member includes a sleeve formed from a flexible membrane and one or more stents disposed at either or both ends of the sleeve. In some embodiments, the stents may be treatment stents configured to treat a portion of the body lumen. The elongate tubular member may be deployed within the body lumen such that the flexible membrane aligns with and moves in coordination with the sphincter, thereby increasing retention forces acting upon the elongate tubular member when the sphincter is closed to minimize treatment stent migration.

A method comprises obstructing at least a portion of an inside of a gallbladder using a barrier, and suppressing, using the barrier, contacting at least a portion of an interior wall of the gallbladder with a bile from a cystic duct.

Engageable stents disclosed herein may include an outer stent comprising an elongate body configured to be expandable between a constrained configuration and an unconstrained configuration. The elongate body in the unconstrained configuration may include a retention member and a cylindrical saddle region adjacent the retention member, the cylindrical saddle region defining a lumen extending along a longitudinal axis of the outer stent. The retention member of the outer stent may comprise a double-walled flange. The engageable stents may include an inner stent comprising an elongate body configured to be expandable between a constrained configuration and an unconstrained configuration. The elongate body in the unconstrained configuration may include a retention member and a cylindrical saddle region adjacent the retention member. The retention member of the inner stent may comprise a double-walled flange. The retention members of the outer and inner stent may be removably engageable with each other.

Medical devices and method for making and using the same are disclosed. An example medical device may include implantable medical device for use along the biliary and/or pancreatic tract. The implantable medical device may include a tubular member having a first end configured to be disposed within the duodenum of a patient and a second end configured to be disposed adjacent to a pancreatic duct and/or bile duct. The tubular member may have a body including one or more wire filaments that are woven together. The tubular member may also have an outer surface with a longitudinal channel formed therein.

Provided is a gastrointestinal stent that can be placed accurately at a placement target site of the gastrointestinal tract. A gastrointestinal stent (large intestine stent 1) is a gastrointestinal stent that is placed inside the gastrointestinal tract (large intestine C) and has a tubular shape. The gastrointestinal stent comprises: a skeleton portion (11) capable of expanding and contracting in a radial direction substantially perpendicular to an axial direction; and a conversion section (restraint string 13) capable of converting one portion (rear end portion 11b) of the skeleton portion in the axial direction from the contracted state to the expanded state while keeping the other portion (front end portion 11a) of the skeleton portion in the contracted state.

Medical devices and method for making and using the same are disclosed. An example medical device may include implantable medical device for use along the biliary and/or pancreatic tract. The implantable medical device may include a tubular member having a first end configured to be disposed within the duodenum of a patient and a second end configured to be disposed adjacent to a pancreatic duct and/or bile duct. The tubular member may have a body including one or more wire filaments that are woven together. The tubular member may also have an outer surface with a longitudinal channel formed therein.